FDA Drugs recall ·

Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4… recall

Recall number
D-0392-2025
Date
(initiated April 15, 2025)
Company / brand
Nubratori, Inc
381 Van Ness Ave Ste 1507, Torrance, CA, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
20 boxes
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative Free, For Iontophoresis Use Only, Non-Sterile Product, Not for Injection, NUBRATORI RX, 381 Van Ness Ave# 1507, CA 90501, NDC 71300-6564-1 (box), 71300-6564-3 (vial).

Why was it recalled?

Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot #: C04292401X1, BUD: 12/25/2025 (box).

Distribution

PA and CA.

States: California Pennsylvania

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0392-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.